Repros Therapeutics, Inc. (RPRX)

[spartex]

I sent Joe P. (CEO) an email regarding updates or conf calls on their Androxal trial plans following the Oct 15 FDA meeting. He said that he'll be "presenting at both the Rodman and CIBC conferences the week of November 5. I will be providing more information at that time. Both presentations will be webcast."

They aren't planning on having any conf calls following the Oct 15 meeting with FDA at this time.